Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 70.50
-1.40 (-1.95%)
At close: Jun 16, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 7.57 billion as of June 16, 2026. Its market cap has increased by 34.54% in one year.
Market Cap
7.57B
Enterprise Value
11.22B
Revenue
10.57B
Ranking
n/a
PE Ratio
12.58
Stock Price
70.50
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 7.57B, an increase of 167.05%. That is a compound annual growth rate of 30.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 7.57B | 35.84% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 25.11B |
| The ACME Laboratories | 17.03B |
| Asiatic Laboratories | 15.19B |
| The IBN SINA Pharmaceutical Industry | 9.80B |
| Orion Pharma | 6.76B |
| Techno Drugs | 5.76B |
| Silco Pharmaceuticals | 2.16B |
| Ambee Pharmaceuticals | 1.83B |